These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22457734)

  • 1. Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France.
    Bone A; Guthmann JP; Assal A; Rousset D; Degeorges A; Morel P; Valette M; Enouf V; Jacquot E; Pelletier B; Le Strat Y; Pillonel J; Fonteneau L; van der Werf S; Lina B; Tiberghien P; Lévy-Bruhl D
    PLoS One; 2012; 7(3):e33056. PubMed ID: 22457734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
    Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
    Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.
    McVernon J; Laurie K; Faddy H; Irving D; Nolan T; Barr I; Kelso A
    Influenza Other Respir Viruses; 2014 Mar; 8(2):194-200. PubMed ID: 24382379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009.
    McVernon J; Laurie K; Nolan T; Owen R; Irving D; Capper H; Hyland C; Faddy H; Carolan L; Barr I; Kelso A
    Euro Surveill; 2010 Oct; 15(40):. PubMed ID: 20946757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia - a seroprevalence study.
    Dowse GK; Smith DW; Kelly H; Barr I; Laurie KL; Jones AR; Keil AD; Effler P
    Med J Aust; 2011 Jan; 194(2):68-72. PubMed ID: 21241219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
    Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
    Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel.
    Weil M; Shohat T; Bromberg M; Bassal R; Dichtiar R; Mandelboim M; Sofer D; Cohen D; Mendelson E
    Influenza Other Respir Viruses; 2013 Sep; 7(5):838-46. PubMed ID: 23280061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.
    Tandale BV; Pawar SD; Gurav YK; Chadha MS; Koratkar SS; Shelke VN; Mishra AC
    BMC Infect Dis; 2010 Aug; 10():255. PubMed ID: 20738878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
    Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
    PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
    McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
    Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic.
    Bandaranayake D; Huang QS; Bissielo A; Wood T; Mackereth G; Baker MG; Beasley R; Reid S; Roberts S; Hope V;
    PLoS One; 2010 Oct; 5(10):e13211. PubMed ID: 20976224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.
    Van Kerkhove MD; Hirve S; Koukounari A; Mounts AW;
    Influenza Other Respir Viruses; 2013 Sep; 7(5):872-86. PubMed ID: 23331969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Pandemic A(H1N1) pmd09 Virus Antibodies in Mexican Health Care Workers Before and After Vaccination.
    Aguilar-Madrid G; Castelán-Vega JA; Juárez-Pérez CA; Ribas-Aparicio RM; Estrada-García I; Baltierra-Jasso L; Cervantes-Servín N; Méndez-Ortega V; Haro-García LC; Sánchez-Román FR; Ortiz-Navarrete V; Fabila-Castillo LH; Magaña-Hernández A; Chávez-Negrete A; Salamanca-Gómez FA; Jiménez-Alberto A
    Arch Med Res; 2015 Feb; 46(2):154-63. PubMed ID: 25796508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planning for the next influenza H1N1 season: a modelling study.
    Carrat F; Pelat C; Levy-Bruhl D; Bonmarin I; Lapidus N
    BMC Infect Dis; 2010 Oct; 10():301. PubMed ID: 20964814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of influenza A (H1N1) seropositivity in unvaccinated healthcare workers in Scotland at the height of the global pandemic.
    Smith K; Warner P; Williams LJ; Adamson WE; Katikireddi SV; Dewart P; Carman WF; Templeton K; Denison FC; Mackenzie DG
    J Environ Public Health; 2011; 2011():407505. PubMed ID: 21977047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The seroprevalence of pandemic influenza H1N1 (2009) virus in China.
    Xu C; Bai T; Iuliano AD; Wang M; Yang L; Wen L; Zeng Y; Li X; Chen T; Wang W; Hu Y; Yang L; Li Z; Zou S; Li D; Wang S; Feng Z; Zhang Y; Yu H; Yang W; Wang Y; Widdowson MA; Shu Y
    PLoS One; 2011 Apr; 6(4):e17919. PubMed ID: 21533034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.
    Gilbert GL; Cretikos MA; Hueston L; Doukas G; O'Toole B; Dwyer DE
    PLoS One; 2010 Sep; 5(9):e12562. PubMed ID: 20830210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence following the first wave of pandemic influenza A (H1N1) in Turkey, 2009.
    Gözalan A; Altaş AB; Sevencan F; Akın L; Korukluoğlu G; Kara S; Sevindi DF; Ertek M;
    Jpn J Infect Dis; 2012; 65(1):13-8. PubMed ID: 22274152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.